These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2510 related articles for article (PubMed ID: 24711255)
1. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma. Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255 [TBL] [Abstract][Full Text] [Related]
2. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise? Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723 [TBL] [Abstract][Full Text] [Related]
3. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy. Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Importance of Bone Marrow Uptake on Baseline Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313 [TBL] [Abstract][Full Text] [Related]
5. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy. Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828 [TBL] [Abstract][Full Text] [Related]
6. [Diagnostic and Prognostic Value of Chen X; Qiao WL; Song JH; Liu CC; Han L; Wu S; Zhao JH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1044-1049. PubMed ID: 37551475 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match? Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Ann Nucl Med; 2015 Feb; 29(2):132-7. PubMed ID: 25348549 [TBL] [Abstract][Full Text] [Related]
8. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma. Hong J; Lee Y; Park Y; Kim SG; Hwang KH; Park SH; Jeong J; Kim KH; Ahn JY; Park S; Park J; Lee JH Ann Hematol; 2012 May; 91(5):687-695. PubMed ID: 22008868 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT. Zhou Z; Chen C; Li X; Li Z; Zhang X; Chang Y; Lu L; Cui Y; Ma Y; Zhang M Ann Hematol; 2015 Jun; 94(6):963-7. PubMed ID: 25547320 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow evaluation in initial staging of lymphoma: 18F-FDG PET/CT versus bone marrow biopsy. Cortés-Romera M; Sabaté-Llobera A; Mercadal-Vilchez S; Climent-Esteller F; Serrano-Maestro A; Gámez-Cenzano C; González-Barca E Clin Nucl Med; 2014 Jan; 39(1):e46-52. PubMed ID: 23640215 [TBL] [Abstract][Full Text] [Related]
11. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma. Adams HJ; Nievelstein RA; Kwee TC Blood Rev; 2015 Nov; 29(6):417-25. PubMed ID: 26113144 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of bone marrow 2-[ Lim CH; Hyun SH; Cho YS; Choi JY; Lee KH Clin Radiol; 2021 Jul; 76(7):550.e19-550.e28. PubMed ID: 33762136 [TBL] [Abstract][Full Text] [Related]
13. PET/CT Scanner and Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma. El Karak F; Bou-Orm IR; Ghosn M; Kattan J; Farhat F; Ibrahim T; Jreige M; El Cheikh J; Haidar M PLoS One; 2017; 12(1):e0170299. PubMed ID: 28099514 [TBL] [Abstract][Full Text] [Related]
15. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography. Vishnu P; Wingerson A; Lee M; Mandelson MT; Aboulafia DM Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378 [TBL] [Abstract][Full Text] [Related]
16. The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study. Alzahrani M; El-Galaly TC; Hutchings M; Hansen JW; Loft A; Johnsen HE; Iyer V; Wilson D; Sehn LH; Savage KJ; Connors JM; Gascoyne RD; Johansen P; Clasen-Linde E; Brown P; Villa D Ann Oncol; 2016 Jun; 27(6):1095-1099. PubMed ID: 27002106 [TBL] [Abstract][Full Text] [Related]
17. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma. Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235 [TBL] [Abstract][Full Text] [Related]
18. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma. Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC Eur J Haematol; 2015 Jun; 94(6):532-9. PubMed ID: 25311082 [TBL] [Abstract][Full Text] [Related]
19. Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study. Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Blase PE; Nievelstein RA; de Klerk JM Skeletal Radiol; 2014 Sep; 43(9):1231-6. PubMed ID: 24902511 [TBL] [Abstract][Full Text] [Related]
20. Detection performance and prognostic value of initial bone marrow involvement in diffuse large B-cell lymphoma: a single centre Doma A; Zevnik K; Studen A; Prevodnik VK; Gasljevic G; Novakovic BJ Radiol Oncol; 2024 Mar; 58(1):15-22. PubMed ID: 38378029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]